Matches in Wikidata for { <http://www.wikidata.org/entity/Q64188965> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q64188965 description "clinical trial" @default.
- Q64188965 description "ensayu clínicu" @default.
- Q64188965 description "klinisch onderzoek" @default.
- Q64188965 description "клінічне випробування" @default.
- Q64188965 name "Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)" @default.
- Q64188965 type Item @default.
- Q64188965 label "Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)" @default.
- Q64188965 prefLabel "Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)" @default.
- Q64188965 P1050 Q64188965-ACCD003F-C4D7-4280-8732-4FBF26DAD768 @default.
- Q64188965 P1132 Q64188965-389763F0-B176-4346-9731-F6E07E021058 @default.
- Q64188965 P1476 Q64188965-4F6568CC-820C-43D8-8FC5-1CE7CF759D56 @default.
- Q64188965 P17 Q64188965-8DD790C7-DB2D-4A3B-92FB-19E96930DDAD @default.
- Q64188965 P2899 Q64188965-55896112-9AC8-4F7B-8089-D10BEF15F944 @default.
- Q64188965 P3098 Q64188965-5CCC0EE1-AB17-4E3C-B0F2-1DC4A9528D7A @default.
- Q64188965 P31 Q64188965-EE89666E-E9AC-4728-BFA6-E636D656C92F @default.
- Q64188965 P580 Q64188965-D1CB613C-647D-4F49-9E07-E9C8D7B72DF7 @default.
- Q64188965 P582 Q64188965-961889DD-6931-48A9-957B-897110B4DAD9 @default.
- Q64188965 P6099 Q64188965-BEE15769-FB7C-4D3D-B0D3-1DE7605199B8 @default.
- Q64188965 P6153 Q64188965-3AD68DAD-4639-41BA-97F7-9F3591DD0A18 @default.
- Q64188965 P6153 Q64188965-524E84D7-5B09-4484-A89D-5D1B3E3EAA9B @default.
- Q64188965 P6153 Q64188965-55481208-2485-4950-BEED-F03D2FC48D77 @default.
- Q64188965 P6153 Q64188965-56E2DD6F-F7D8-42A6-9C6F-86B9BBC6317F @default.
- Q64188965 P6153 Q64188965-C1830D41-FFA0-4A3B-9BA9-0847125A7781 @default.
- Q64188965 P8363 Q64188965-C1DF3788-98C5-4642-907C-30124B360765 @default.
- Q64188965 P1050 Q29496 @default.
- Q64188965 P1132 "+80" @default.
- Q64188965 P1476 "A Phase 1, Open-label, Dose-escalation, Multicenter Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Activity of ADCT 301 in Patients With Relapsed or Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia" @default.
- Q64188965 P17 Q30 @default.
- Q64188965 P2899 "+18" @default.
- Q64188965 P3098 "NCT02588092" @default.
- Q64188965 P31 Q30612 @default.
- Q64188965 P580 "2015-12-01T00:00:00Z" @default.
- Q64188965 P582 "2018-08-29T00:00:00Z" @default.
- Q64188965 P6099 Q5452194 @default.
- Q64188965 P6153 Q131252 @default.
- Q64188965 P6153 Q1808012 @default.
- Q64188965 P6153 Q30282233 @default.
- Q64188965 P6153 Q621043 @default.
- Q64188965 P6153 Q96149477 @default.
- Q64188965 P8363 Q78089383 @default.